The Global Lung Cancer Screening Market Report, published by Emergen Research, offers an industry-wide assessment of the Lung Cancer Screening Market, which is inclusive of the most crucial factors contributing to the growth of the industry. The latest research report comprises an extensive analysis of the micro- and macro-economic indicators that influence the global market development during the forecast period of 2022-2030.
The global lung cancer screening market size was USD 2.80 Billion in 2021 and is expected to register a revenue CAGR of 8.1% during the forecast period. High cigarette consumption increasing incidence of lung cancer is a major factor driving market revenue growth.
Get Free Sample PDF Brochure @https://www.emergenresearch.com/request-sample/1328
Lung cancer is one of the main causes of cancer death, accounting for around 25% of all cancer fatalities. Cigarette smoking has been identified as a significant risk factor for developing Non-Small Cell Lung Cancer (NSCLC), along with other environmental and genetic risk factors. Approximately 80% of lung cancer fatalities are caused by smoking, with remaining being caused by secondhand smoke exposure.
According to World Health Organization, rise in worldwide tobacco consumption, particularly in Asia, is responsible for a continued rise in lung cancer mortality. In addition, lung cancer cases has been increased due to factors such as water pollution, age, radiation exposure, air pollution (polycyclic aromatic hydrocarbons), and prolonged exposure to certain chemicals, gases, or pollutants including asbestos, beryllium, arsenic, nickel, and chromium.
Key insights presented in the report:
Market revenue shares by major business players, by type, by application, and market scope of global Lung Cancer Screening market
Sales revenue by key players and new entrants
Competitive analysis of key players, including aspects such as company overview, product or services specification, vendors, and buyers
Recent mergers, acquisitions, product launches, recent investments, and joint ventures
Regional analysis to provide insight into recent trends and opportunities
To know more about the report @https://www.emergenresearch.com/industry-report/lung-cancer-screening-market
Competitive Terrain:
The Global Lung Cancer Screening Market is highly consolidated due to the presence of a large number of companies across this industry. The report discusses the current market standing of these companies, their past performances, demand and supply graph, production and consumption patterns, sales network, distribution channels, and growth opportunities in the market at length. The report scrutinizes the strategic approach of key market players towards expanding their product offerings and fortifying their market foothold.
The leading market contenders listed in the report are as follows:
Koninklijke Philips N.V., Siemens Healthcare GmbH, Canon Medical Systems Corporation, General Electric Company, FUJIFILM Holdings Corporation, Medtronic, Nuance Communications, Inc., Eon, PenRad Technologies Inc., and Volpara Health Limited.
The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.
Emergen Research has segmented the global lung cancer screening market based on cancer type, diagnosis type, end-use, and region:
-
Cancer Type Outlook (Revenue, USD Billion; 2019-2030)
- Non-small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer
-
Diagnosis Type Outlook (Revenue, USD Billion; 2019-2030)
- Low Dose Spiral CT Scan
- Chest X-Ray
-
End-use Outlook (Revenue, USD Billion; 2019-2030)
- Hospitals & Clinics
- Diagnostic Centers
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@https://www.emergenresearch.com/request-discount/1328
Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Regional Outlook of Lung Cancer Screening Market:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
Key point summary of the report:
The report offers a comprehensive overview of the market size, share, and growth rate in the forecast duration.
It provides details about current scenario, historical data, giving an accurate market forecast for the coming years.
The study categorizes the market on the basis of product types, applications, end users, market value and volume, business verticals, and 5 major regions.
It also offers regional market analysis and forecast for prominent geographies in the sector viz., North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Industry supply chain, sourcing strategy, upstream feedstock, and downstream demand analysis has also been undertaken in the research report.
The study offers a comprehensive understanding of the demand and supply dynamics, including production and consumption rates, and mapping of the overall market.
The report employs different analytical tools including, SWOT analysis, Porter’s five forces analysis, and pricing analysis, to give precise market information.
Request Customization as per your specific requirement@https://www.emergenresearch.com/request-for-customization/1328
Thank you for reading the research report. We also offer report customization as per client requirement. Kindly connect with us to know more about the customization feature and our team will offer you the best suited report.
Take a Look at our Related Reports:
About Us:
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek